IMD-Pharma

IMD-Pharma S.A.S is a french biotechnology company conducting research and development of innovative drug candidates for immune-related inflammatory diseases.

http://www.imd-pharma.com/
 

Advisory board:

Marc Cluzel, MD – Founder of C&F Consulting - Former Head of Global R&D at Sanofi

Claude Allary, PhD - Founder of Bionest Partners.

Jacques Peuscet, IP attorney (more 30 years as patent attorney, IP attorney for l’Oréal).

Alexis Denis, PhD - Director Discovery at Oncodesign: Broad range of experience in R&D and Medchem (Aventis, Pfizer, Mutabilis, GSK).

Pierre Gressens, MD, PhD - Professor of Perinatal Neurology at Hammersmith Hospital, Imperial College of London, and Director of the INSERM U676 research center (perinatal neurology):  researcher and child neurologist at Robert Debré Hospital, Paris, since 1995.

Alexandre Prat, MD, PhD - Full Professor, Department of Neurosciences (Université de Montréal), Director of Neuroimmunology Research Laboratory (CRCHUM), Physician atthe Division of Neurology (CHUM), Canada Research Chair in Multiple Sclerosis